-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 7, Hengrui Pharmaceutical announced that its subsidiary Chengdu Shengdi Pharmaceutical received the "Approval Notice for Supplementary Drug Application" approved and issued by the State Drug Administration, and Fexofenadine Hydrochloride Tablets passed the quality and Efficacy consistency evaluation
The indications for this drug are:
1.
Indicated to relieve symptoms associated with seasonal allergic rhinitis such as sneezing, runny nose, itchy nose, palate, throat, itchy, wet, red eyes in adults and children 6 years and older
2.
Indicated for the treatment of skin symptoms of chronic idiopathic urticaria in adults and children 6 years of age and older, reducing itching and the number of wheals
Fexofenadine hydrochloride is an antihistamine with selective peripheral H1-receptor antagonism
After querying the EvaluatePharma database, the global sales of fexofenadine hydrochloride-related dosage forms in 2020 were approximately US$636 million